Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein

Award Number: F31AI179463
ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS
PERIOD OF PERFORMANCE START DATE: 03/01/2024
PERIOD OF PERFORMANCE END DATE: 06/23/2025

Group Awards By:

View Award Description

The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein - Abstract The humoral immune system relies on the rich diversity of the antibody binding repertoire to generate targeted responses to the vast array of antigens one may encounter, and much work has been done to characterize the factors generating this diversity. However, allelic variation at the highly polymorphic immunoglobulin heavy chain (IGH) gene locus has remained largely unexplored as a factor impacting the specificity of antibody responses to both infection and vaccination. While many antigens are capable of eliciting strong neutralizing responses across the population regardless of IGH haplotype, recent studies have shown that certain alleles encoding IGH gene segments impact the magnitude of neutralizing antibody responses to viral antigens in humans. Differential development of neutralizing antibody titers in response to HIV immunogens across individuals is well documented, with only around 20% of HIV infected individuals developing broadly neutralizing antibodies (bNAbs). Similarly, BG505.SOSIP.664, a tier 2 HIV envelope glycoprotein (env) immunogen, has been shown to elicit a wide range of humoral responses in rhesus macaques (RM), with some developing high titers of nAbs capable of protection against autologous SHIV challenge, while others develop very low nAb titers not capable of such protection. We hypothesize that germline IGH polymorphisms and allelic representation within the antigen specific B cell repertoire contribute to the variation in Nab titers observed in response to BG505 SOSIP.664 vaccination. The goal of this project is to determine how allelic variation at IGH genes in rhesus macaques affects the development of nAbs, in the following two Specific Aims: (1) to identify IGH polymorphisms in RM vaccinated with BG505SOSIP.644 associated with differential development of nAb titers (2) to identify the epitope specificity of the antibody repertoire encoded by alleles associated most strongly with high nAb titers. These experiments will uncover a factor contributing to the diversity of humoral immune responses at the population level, and in doing so we will contribute to the establishment of a non-human primate model for studying the effects of genotype on antibody responses to vaccines against various human pathogens. Our results will greatly enhance the rational design and development of germline targeting vaccines.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = $27,111 )
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	001	2	7/31/2025	NON-COMPETING CONTINUATION	$564
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	002	2	8/21/2025	NON-COMPETING CONTINUATION	-$22,427
2025	2025	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	2	4/29/2025	NON-COMPETING CONTINUATION	$48,974
														Subtotal = $27,111

Issue Date FY: 2024 ( Subtotal = $48,974 )
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	001	1	2/23/2024	NEW	$0
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR NE	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	002	1	5/8/2024	NEW	$1,280
2024	2024	EMORY UNIVERSITY	201 DOWMAN DR	ATLANTA	GA	30322	DEKALB	USA	Allergy and Infectious Diseases Research	000	1	2/23/2024	NEW	$47,694
														Subtotal = $48,974

Grand Total All Awards = $76,085

Top

All Categories

About

Search

Reports

Data Submission

Award Information

The Role of Immunoglobulin Genetic Diversity in the Development of Neutralizing Antibodies Against HIV Env Protein

Award Number: F31AI179463

ORGANIZATION: NATIONAL INSTITUTE OF ALLERGY & INFECTIOUS DISEASES

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: FELLOWSHIP/SCHOLARSHIP/STUDENT LOANS

PERIOD OF PERFORMANCE START DATE: 03/01/2024

PERIOD OF PERFORMANCE END DATE: 06/23/2025

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer